Rad Tech CE, ASRT, ARRT® CE, Category A Credits | Radiology Continuing Education

Approvals/Requirements Satisfied by eRADIMAGING Courses

  • ASRT approval for ARRT Category A credit
  • All Courses eligible of international radiographers' CPD requirements
  • ASRT and MDCB are approved continuing education providers of ARRT and all courses are accepted by ARRT
  • California CE requirements met for all radiography courses
  • NMTCB accepted (All Courses)
  • All Courses available for RRAs
  • ARMRIT accepted (All MRI Courses)
  • MDCB approval by the Medical Dosimetrist Certification (Selected Courses)
  • Florida approval for all courses 1 credit or more
  • ARDMS accepted (All Courses)
  • CAMRT and Sonography Canada recognize the ASRT approval (All Courses)
  • Approval: -
  • Release Date: 7/23/2021
  • Expiration Date: 8/1/2024
  • Credit Hours: 3.5 Credits
  • ACCME Approval: This course is approved by the ACCME. (Release Date: 8/24/2021  Expiration Date: 8/24/2023)
  • Course Description and objectives:

    Course Description
    Breast cancer (BC) is a significant healthcare issue, and screening for breast cancer remains one of the most controversial. Mammography screening is still the best approach to reduce the burden of premature death. Balancing the benefits and limitations, as well as the potential harms of mammography and other imaging modalities, along with assessing the patient's risk profile for BC and their preferences, provides the best approach to optimize screening strategies for individual women. This course will examine current screening recommendations and discuss reasons for their differences, how screening tests are assessed, the benefits and limitations of mammography, as well as the impact of combining other imaging modalities with mammography to enhance its predictive value. Other technologies and their potential impact on BC screening will also be discussed.

    Over the past decade, women of color and those with lower income or education levels were less likely to receive appropriate BC screening compared with white women and the more educated and affluent. This course will explore how this gap has narrowed over time. Finally, the important role of radiologic technologists and mammographers and what they provide regarding BC screening will also be addressed, as well as how screening requires a personalized approach that integrates patient-specific and age-dependent metrics of cancer risk with selective application of specific screening technologies best suited to the patient's age, risk, and breast density.

    Learning Objectives

    After completing this course, the participant should be able to:

    • DEFINE the performance measures for assessing the validity of a breast cancer screening test.
    • OUTLINE the differences in breast cancer screening recommendations.
    • IDENTIFY patient parameters that impact the choice of a breast cancer screening with mammography, sonography, and magnetic resonance imaging.
    • IDENTIFY risk factors that impact the need for personalized screening.
    • EXPLAIN how breast density impacts various breast screening technologies.
    • EXPLAIN when and why different breast screening imaging technologies should be used.
    • LIST options for optimizing breast cancer screening with mammography.
    • OUTLINE current approaches to addressing breast density on mammographic screening.
    • IDENTIFY healthcare disparities in breast cancer screening.
    • ANALYZE the potential impact of coronavirus disease 2019 (COVID-19) vaccination on mammograms.
    • OUTLINE strategies for radiologic technologists and mammographers to improve breast cancer screening with mammography.

     

    Categories: Mammography, Magnetic Resonance Imaging (MRI), Ultrasound/Sonography, Professional Development/Patient Care Quality

  • CE Information:

    In order to receive CE credit, you must first complete the activity content. When completed, go to the "Take CE Test!" link to access the post-test.

    Submit the completed answers to determine if you have passed the post-test assessment. You must answer 21 out of 28 questions correctly to receive CE credit. You will have no more than 3 attempts to successfully complete the post-test.

    Participants successfully completing the activity content and passing the post-test will receive 3.5 ARRT Category A credits.

    Approved by the American Society of Radiologic Technologists for ARRT Category A credit.

    Approved by the state of Florida for ARRT Category A credit.

    Texas direct credit.

    This activity may be available in multiple formats or from different sponsors. ARRT does not allow CE activities such as Internet courses, home study programs, or directed readings to be repeated for CE credit in the same biennium.

    For ACCME Credit Provided by AKH Inc.

    Release Date: 8/24/2021

    Expiration Date: 8/24/2023

    Target Audience
    This activity is designed to meet the needs of Radiologic Technologists and Physicians, specifically Radiologists.

    Method of Participation
    In order to receive credit, participants should complete the pre-test, review the content, and continue to the post-test and evaluation. A certificate will generate upon successful submission of the post-test and evaluation. If you have questions about this CME activity, please contact AKH Inc. at jgoldman@akhcme.com.

    CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.  This activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and eRADIMAGING.

     

    In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and eRADIMAGING. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Commercial Support
    There is no commercial support for this activity.

    Disclosures
    None of the planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

    It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The planners and faculty must disclose to the participants any significant relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients." or with the commercial supporter of this accredited continuing education activity. Identified conflicts of interest are mitigated by AKH prior to the planners/faculty assuming their role in this accredited continuing education activity.

    Disclosure of Unlabeled Use and Investigational Products
    This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer
    This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

  • Structured Education Credit Valuations:

    CategoryContent AreaCredits
    Breast SonographyPatient Care3
    Magnetic ResonancePatient Care1
    Magnetic ResonanceProcedures1
    MammographyPatient Care1
    MammographyProcedures2.25
    Nuclear MedicinePatient Care1
    Nuclear MedicineProcedures0.5
    Radiation TherapyPatient Care3
    Radiologist AssistantProcedures3.25
    SonographyPatient Care1
    SonographyProcedures1

  • CQR Credit Valuations:

    CategorySubcategoryCredits
    Breast SonographyPatient Interactions and Management 3
    Magnetic ResonanceBody1
    Magnetic ResonancePatient Interactions and Management 1
    MammographyMammographic Positioning, Special Needs and Imaging Procedures2.25
    MammographyPatient Interactions and Management 1
    Nuclear MedicineEndocrine and Oncology Procedures0.5
    Nuclear MedicinePatient Interactions and Management 1
    Radiation TherapyPatient and Medical Records Management3
    Radiologist AssistantThoracic Section 3.25
    SonographyPatient Interactions and Management 1
    SonographySuperficial Structures and Other Sonographic Procedures1


Breast Cancer Screening: Resolving the Differences in Benefits and Harms

Linda Giering, PhD*

*Medical Writer, Matawan, New Jersey.

Address correspondence to: Linda Giering, PhD. E-mail: lindagiering@gmail.com.

Disclosure statement: The author reports having no significant financial or advisory relationships with corporate organizations related to this activity.

ABSTRACT

Breast cancer (BC) is a significant healthcare issue, and screening for breast cancer remains one of the most controversial. Mammography screening is still the best approach to reduce the burden of premature death. Balancing the benefits and limitations, as well as the potential harms of mammography and other imaging modalities, along with assessing the patient's risk profile for BC and their preferences, provides the best approach to optimize screening strategies for individual women. This course will examine current screening recommendations and discuss reasons for their differences, how screening tests are assessed, the benefits and limitations of mammography, as well as the impact of combining other imaging modalities with mammography to enhance its predictive value. Other technologies and their potential impact on BC screening will also be discussed.

Over the past decade, women of color and those with lower income or education levels were less likely to receive appropriate BC screening compared with white women and the more educated and affluent. This course will explore how this gap has narrowed over time. Finally, the important role of radiologic technologists and mammographers and what they provide regarding BC screening will also be addressed, as well as how screening requires a personalized approach that integrates patient-specific and age-dependent metrics of cancer risk with selective application of specific screening technologies best suited to the patient's age, risk, and breast density.

View the full content

Sample eRADIMAGING Course *

* This sample course is for reference purposes only. It is not currently available for earning CE credits. To earn ARRT CE credits please subscribe to eRADIMAGING where you will see a complete listing of all active and eligible CE courses.

Become a member

Satisfy your CE requirements today!

Join now

We offer special group rates, call or email.

984.227.8560

support@eradimaging.com

Newsletter

Enter your email address to receive our new course alerts.